PROCTER & GAMBLE HEALTH | ORCHID PHARMA | PROCTER & GAMBLE HEALTH/ ORCHID PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.8 | 43.7 | 79.5% | View Chart |
P/BV | x | 10.6 | 8.1 | 131.6% | View Chart |
Dividend Yield | % | 2.0 | 0.0 | - |
PROCTER & GAMBLE HEALTH ORCHID PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
ORCHID PHARMA Mar-23 |
PROCTER & GAMBLE HEALTH/ ORCHID PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 439 | 1,223.6% | |
Low | Rs | 3,883 | 273 | 1,421.8% | |
Sales per share (Unadj.) | Rs | 740.7 | 163.1 | 454.1% | |
Earnings per share (Unadj.) | Rs | 138.2 | 13.5 | 1,021.4% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 27.0 | 575.6% | |
Dividends per share (Unadj.) | Rs | 95.00 | 0 | - | |
Avg Dividend yield | % | 2.1 | 0 | - | |
Book value per share (Unadj.) | Rs | 447.6 | 168.7 | 265.3% | |
Shares outstanding (eoy) | m | 16.60 | 40.82 | 40.7% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 2.2 | 286.2% | |
Avg P/E ratio | x | 33.5 | 26.3 | 127.3% | |
P/CF ratio (eoy) | x | 29.8 | 13.2 | 225.8% | |
Price / Book Value ratio | x | 10.3 | 2.1 | 489.9% | |
Dividend payout | % | 68.7 | 0 | - | |
Avg Mkt Cap | Rs m | 76,761 | 14,522 | 528.6% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 654 | 315.5% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 6,659 | 184.7% | |
Other income | Rs m | 184 | 194 | 94.6% | |
Total revenues | Rs m | 12,480 | 6,853 | 182.1% | |
Gross profit | Rs m | 3,247 | 1,235 | 262.9% | |
Depreciation | Rs m | 281 | 548 | 51.3% | |
Interest | Rs m | 8 | 329 | 2.3% | |
Profit before tax | Rs m | 3,142 | 552 | 568.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 0 | - | |
Profit after tax | Rs m | 2,295 | 552 | 415.4% | |
Gross profit margin | % | 26.4 | 18.5 | 142.4% | |
Effective tax rate | % | 27.0 | 0 | - | |
Net profit margin | % | 18.7 | 8.3 | 224.9% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 5,010 | 233.8% | |
Current liabilities | Rs m | 6,791 | 3,719 | 182.6% | |
Net working cap to sales | % | 40.0 | 19.4 | 206.4% | |
Current ratio | x | 1.7 | 1.3 | 128.0% | |
Inventory Days | Days | 263 | 57 | 458.1% | |
Debtors Days | Days | 343 | 1,180 | 29.1% | |
Net fixed assets | Rs m | 10,617 | 7,242 | 146.6% | |
Share capital | Rs m | 166 | 408 | 40.7% | |
"Free" reserves | Rs m | 7,265 | 6,478 | 112.1% | |
Net worth | Rs m | 7,431 | 6,886 | 107.9% | |
Long term debt | Rs m | 0 | 1,488 | 0.0% | |
Total assets | Rs m | 22,330 | 12,252 | 182.3% | |
Interest coverage | x | 409.1 | 2.7 | 15,268.0% | |
Debt to equity ratio | x | 0 | 0.2 | 0.0% | |
Sales to assets ratio | x | 0.6 | 0.5 | 101.3% | |
Return on assets | % | 10.3 | 7.2 | 143.3% | |
Return on equity | % | 30.9 | 8.0 | 384.9% | |
Return on capital | % | 42.4 | 10.5 | 402.7% | |
Exports to sales | % | 0 | 81.9 | 0.0% | |
Imports to sales | % | 13.1 | 37.6 | 34.8% | |
Exports (fob) | Rs m | NA | 5,452 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 2,501 | 64.2% | |
Fx inflow | Rs m | 1,465 | 5,452 | 26.9% | |
Fx outflow | Rs m | 1,605 | 2,726 | 58.9% | |
Net fx | Rs m | -140 | 2,726 | -5.1% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 183 | 1,286.9% | |
From Investments | Rs m | -215 | -312 | 68.9% | |
From Financial Activity | Rs m | -985 | 312 | -316.0% | |
Net Cashflow | Rs m | 1,160 | 183 | 634.4% |
Indian Promoters | % | 0.0 | 69.8 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 19.7 | 101.4% | |
FIIs | % | 6.2 | 2.0 | 318.4% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 30.2 | 159.7% | |
Shareholders | 56,778 | 36,720 | 154.6% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: CIPLA DIVIS LABORATORIES SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | Orchid Pharma | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.18% | 2.95% | 0.97% |
1-Month | -0.72% | 2.64% | 2.08% |
1-Year | -0.85% | 177.38% | 55.37% |
3-Year CAGR | -8.62% | -13.74% | 15.04% |
5-Year CAGR | 5.02% | 192.61% | 19.56% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the Orchid Pharma share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of Orchid Pharma the stake stands at 69.8%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of Orchid Pharma.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
Orchid Pharma paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of Orchid Pharma.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.